BioCentury
ARTICLE | Clinical News

Avelumab: Phase II data

May 23, 2016 7:00 AM UTC

Top-line data from 61 evaluable patients with metastatic MCC that has progressed following chemotherapy and who were followed for >=24 weeks in the open-label, international Phase II JAVELIN Merkel 20...